Abstract
US has a number of characteristics which make it a very useful diagnostic technique both for general application and for oncology in particular. First of all, US is a simple technique. This simplicity, which is sometimes confused with ease of use, is related to the way the examination is performed. No preliminary analysis or special preparation is required and it can always be immediately carried out, making it much more accessible in any hospital setting than the “heavy” devices of CT and MR. The immediacy of the image is another advantage, whereby the clinical picture may be clarified at the very time the US transducer is placed on the skin in the anatomic area in question. In addition, the rapidity of the examination is an important characteristic, particularly in other areas, such as emergency medicine. In oncology, however, a careful and comprehensive study is recommended, which slowly and repeatedly explores all the anatomic areas involved in the examination in question. This is particularly important in the “positive” patient: a pathologic finding indicating malignancy in a particular organ should increase the level of attention of the US operator due to the elevated probability that there are other associated findings.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Belton AL et al (2003) Tumour size measurement in an oncology clinical trial: comparison between off-site and onsite measurements. Clin Radiol 58:311–314
Catalano O et al (2004) Ethical, deontologic, social, and economic reflections on screening with helical CT. Part I: general aspects. Radiol Med 108:299–309
Catalano O et al (2004) Ethic, deontologic, social, and economic reflections on screening with helical CT. Part II: specific aspects. Radiol Med 108:310–319
Black WC et al (1997) Screening for disease. AJR Am J Roentgenol 168:3–11
Herman CR et al (2002) Screening for preclinical disease. Test and disease characteristics. AJR Am J Roentgenol 179:825–831
Stanley RJ (2001) Inhert dangers in radiologic screening. AJR Am J Roentgenol 177:989–992
Obuchowski NA et al (2001) Ten criteria for effective screening: their application to multislice CT screening for pulmonary and colorectal cancers. AJR Am J Roentgenol 176:1357–1362
Baker SR (2003) Abdominal CT screening: inflated promises, serious concerns. AJR Am J Roentgenol 180:27–30
Berg WA (2004) Supplemental screening sonography in dense breasts. Radiol Clin North Am 42:845–851
Eden K et al (2001) Screening high-risk populations for thyroid cancer. Med Pediatr 36:583–591
Suehiro F (2006) Thyroid cancer detected by mass screening over a period of 16 years at a health care center in Japan. Surg Today 36:947–953
Park JS et al (2006) Sonographic screening for thyroid cancer in females undergoing breast sonography. AJR Am J Roentgenol 186:1025–1028
Kane RA et al (2003) Ultrasound of the thyroid and parathyroid glands. Controversies in the diagnosis of thyroid cancer. Ultrasound Q 19:177–178
Mihmanli I et al (2006) Concurrent routine breast and thyroid sonography for detection of thyroid tumors (letter). AJR Am J Roentgenol 187:W448
Miki H et al (1998) Value of mass screening for thyroid cancer. World J Surg 22:99–102
Clements R (2001) Ultrasound of prostate cancer. Eur Radiol 11:2119–2125
Sharma A et al (2006) Screening for gynaecological cancers. Eur J Surg Oncol 32:818–824
Ascher SM et al (2002) Cancer of the adnexal organs. In: Bragg DG et al (eds) Oncologic imaging. WB Saunders Company, Philadelphia, 549–574
Hensley ML et al (2004) Cancer screening: how good is good enough?. J Clin Oncol 22:4037–4039
De Priest PD et al (1992) Transvaginal ultrasound screening for ovarian cancer. Clin Obstet Gynecol 35:40–44
Jeong et al (2000) Imaging evaluation of ovarian masses. Radiographics 20:1445–1470
Jacobs I et al (1993) Prevalence screening for ovarian cancer in postmenopausal women by CA-125 measurement and ultrasonography. BMJ 306:1030–1034
Valenzano M et al (2001) The role of transvaginal ultrasound and sonohysterography in the diagnosis and staging of endometrial adenocarcinoma. Radiol Med 101:365–370
Vuento MH et al (1999) Screening for endometrial cancer in asymptomatic postmenopausal women with conventional and color Doppler sonography. Br J Obstet Gynaecol 106:14–20
Fleischer AC (1997) Transvaginal sonography of endometrial cancer. In: Fleischer AC et al (eds) Ultrasound and the endometrium. Parthenon Publishing Group, New York, 69–74
Kim B et al (2003) Testicular microlithiasis: clinical significance and review of the literature. Eur Radiol 13:2567–2576
de Leval J et al (1993) Testis tumor: the problem of the undescended testis. J Belge Radiol 76:100–101
Giwercman A et al (1989) Prevalence of carcinoma in situ and other histopatological abnormalities in the testes of men with a history of cryptorchidism. J Urol 142:998–1002
Miller FN et al (2007) Testicular calcification and microlithiasis: association with primary intra-testicular malignancy in 3,477 patients. Eur Radiol 17:363–369
Rashid HH et al (2004) Testicular microlithiasis: a review and its association with testicular cancer. Urol Oncol 22:285–289
Bruix J et al (2005) Management of hepatocellular carcinoma. Hepatology 42:1208–1236
Colombo M (2005) Natural history of hepatocellular carcinoma. Cancer Imaging 5:85–88
Rockall TA et al (2004) Multidisciplinary treatment for cancer: surgery, chemotherapy and radiotherapy. In: Husband JE et al (eds) Imaging in oncology. Taylor & Francis, London, 43–65
Sangiovanni A et al (2004) Increased survival of cirrhotic patients with a hepatocellular carcinoma detected during surveillance. Gastroenterology 126:1005–1014
Ren F-Y et al (2006) Efficacy of ultrasonography and alphafetoprotein on early detection of hepatocellular carcinoma. World J Gastroenterol 12:4656–4659
Arguedas MR et al (2003) Screening for hepatocellular carcinoma in patients with hepatitis C cirrhosis: a costutility analysis. Am J Gastroenterol 98:679–690
Peterson MS et al (2000) Pretransplantation surveillance for possible hepatocellular carcinoma in patients with cirrhosis: epidemiology and CT-based tumor detection rate in 430 cases with surgical-pathologic correlation. Radiology 217:743–749
Federle MP (2002) Use of radiologic techniques to screen for hepatocellular carcinoma. J Clin Gastroenterol 35 (5 Suppl 2):92–100
Kubota K et al (2003) Growth rate of primary single hepatocellular carcinoma: determining optimal screening interval with contrast enhanced computed tomography. Dig Dis Sci 48:581–586
Majima Y (1984) Growth rate of hepatocellular carcinoma by ultrasonography and its clinical significance. Acta Hepatol Jpn 25:754–765
Hirata K et al (1997) Mass screening for hepatocellular carcinoma by ultrasonography In: Gandolfi L et al (eds), Current trends in digestive ultrasonography. Karger, Basel, 17–27
Bennett GL et al (2002) Sonographic detection of hepatocellular carcinoma and dysplastic nodules in cirrhosis: correlation of pretransplantation sonography and liver explant pathology in 200 patients. AJR Am J Roentgenol 179:75–80
Dodd GD et al (1992) Detection of malignant tumors in endstage cirrhosis livers: efficacy of sonography as a screening technique. AJR Am J Roentgenol 159:727–733
Liu WC et al (2003) Poor sensitivity of sonography in detection of hepatocellular carcinoma in advanced liver cirrhosis: accuracy of pretransplantation sonography in 118 patients. Eur Radiol 13:1693–1698
Bruix J et al (2001) Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 35:4214–30
Bosniak MA et al (1995) Small renal parenchymal neoplasms: further observations on growth. Radiology 197:589–597
Jamis-Dow CA et al (1996) Small (≤3-cm) renal masses: detection with CT versus US and pathologic correlation. Radiology 198:785–788
Mihara S et al (1998) Efficacy of ultrasonic mass survey for abdominal cancer. J Med Syst 22:55–62
Mihara S et al (1999) Early detection of renal cell carcinoma by ultrasonographic screening. Based on the results of 13 years screening in Japan. Ultrasound Med Biol 25:1033–1039
Jeswani T et al (2005) Imaging tumour angiogenesis. Cancer Imaging 5:131–138
Nishida T (2005) Angiogenesis, which is essential for cancer growth, is a diagnostic and therapeutic target. J Gastroenterol 40:320–321
Kelland LR (2005) Targeting established tumor vasculature: a novel approach to cancer treatment. Curr Cancer Ther Rev 1:1–9
Rehman S et al (2005) Molecular imaging of antiangiogenic agents. Oncologist 10:92–103
Cuenod CA et al (2006) Tumor angiogenesis: pathophysiology and implications for contrast-enhanced MRI and CT assessment. Abdom Imaging 31:188–193
Cosgrove D (2003) Angiogenesis imaging — ultrasound. Br J Radiol 76:S43–S49
Anderson H et al (2001) Measuring changes in human tumour vasculature in response to therapy using functional imaging techniques. Br J Cancer 85:1085–1093
Forsberg F et al (2002) Comparing contrast-enhanced ultrasound to immunohistochemical markers of angiogenesis in a human melanoma xenograft model: preliminary results. Ultrasound Med Biol 28:445–451
Provenzale JM (2007) Imaging of angiogenesis: clinical techniques and novel imaging methods. AJR Am J Roentgenol 188:11–23
Ferrara KW et al (2000) Evaluation of tumor angiogenesis with US: imaging, Doppler, and contrast agents. Acad Radiol 7:824–839
Delorme S et al (2006) Contrast-enhanced ultrasound for examining tumor biology. Cancer Imaging 6:148–152
Kruskal JB et al (2006) Will improved assessment of response to antiangiogenic therapies be achieved with contrast-enhanced gray-scale US?. Radiology 240:1–2
Cosgrove D (2003) Angiogenesis imaging-ultrasound. Br J Radiol 76:S43–S49
Blomley MJ et al (1998) Liver vascular transit time analyzed with dynamic hepatic venography with bolus injections of a US contrast agent: early experience in seven patients with metastases. Radiology 209:862–866
Donnelly EF et al (2001) Quantified power Doppler US of tumor blood flow correlates with microscopic quantification of tumor blood vessels. Radiology 219:166–170
Schroeder RJ et al (2001) Tumor vascularization in experimental melanomas: correlation between unenhanced and contrast enhanced power Doppler imaging and histological grading. Ultrasound Med Biol 27:761–771
Lassau N et al (2006a) Gastrointestinal stromal tumors treated with Imatinib: monitoring response with contrast-enhanced sonography. AJR Am J Roentgenol 187:1267–1273
Lucidarme O et al (2004) Angiogenesis model for ultrasound contrast research: exploratory study. Acad Radiol 11:4–12
Pollard RE et al (2002) Contrast-assisted destruction-replenishment ultrasound for the assessment of tumor microvasculature in a rate model. Technol Cancer Res Treat 1:459–470
Fleischer AC et al (2008) Contrast-enhanced transvaginal sonography of benign versus malignant ovarian masses: preliminary findings. J Ultrasound Med 27:1011–1018
Li J et al (2005) Time-intensity-based quantification of vascularity with single-level dynamic contrast-enhanced ultrasonography. A pilot animal study. J Ultrasound Med 24:975–983
Rubaltelli L et al (2007) Automated quantitative evaluation of lymph node perfusion on contrast-enhanced sonography. AJR Am J Roentgenol 188:977–983
Du J et al (2008) Correlation of real-time gray scale contrast-enhanced ultrasonography with microvessel density and vascular endothelial growth factor expression for assessment of angiogenesis in breast lesions. J Ultrasound Med 27:821–831
McCarville MB et al (2006) Angiogenesis inhibitors in a murine neuroblastoma model: quantitative assessment of intratumoral blood flow with contrast-enhanced gray-scale US. Radiology 240:73–81
Krix M et al (2003) Sensitive noninvasive monitoring of tumor perfusion during antiangiogenic therapy by intermittent bolus-contrast power Doppler sonography. Cancer Res 63:8264–8270
Galiè M et al (2005) Tumor vessel compression hinders perfusion of ultrasonographic contrast agents. Neoplasia 7:528–536
Lindner JR (2004) Molecular imaging with contrast ultrasound and target microbubbles. J Nucl Cardiol 11:215–221
Neal AJ (2004) Staging of cancer. In: Husband JE et al (eds) Imaging in oncology. Taylor & Francis, London, 31–41
Wittekind Ch et al (2005) TNM atlas. Springer-Verlag Berlin.
Ferrozzi F et al (2002) Structural changes induced by antineoplastic therapies: keys to evaluate tumor response to treatment. Eur Radiol 12:928–937
Husband JE (1996) Monitoring tumor response. Eur Radiol 6:775–785
Lagalla R et al (1998b) Monitoring treatment response with color and power Doppler Eur J Radiol 28:149–156
MacVicar D et al (1997) Assessment of response following treatment for malignant disease. Br J Radiol 70:41–49
Miller AB et al (1981) Reporting results of cancer treatment. Cancer 47:207–214
Therasse P et al (2000) New guidelines to evaluate the response to treatment in solid tumors. J Natl Cancer Inst 92:205–216
Therasse P et al (2006) RECIST revisited: a review of validation studies on tumour assessment. Eur J Cancer 42:1031–1039
Park SH et al (2004) Volumetric tumor measurement using three-dimensional ultrasound: in vitro phantom study on measurement accuracy under various scanning condition. Ultrasound Med Biol 30:27–34
Bellomi M et al (2004) Evaluation of the response to therapy of neoplastic lesions. Radiol Med 107:450–458
Ollivier L et al (2002) Monitoring tumor response. Cancer Imaging 3:5–6
Prasad SR et al (2003a) Radiological evaluation of oncologic treatment response: current update. Cancer Imaging 3:93–95
Catalano O et al (1999) Hepatocellular carcinoma treated with chemoembolization: assessment with contrast-enhanced Doppler ultrasonography. Cardiovasc Intervent Radiol 22:486–492
Gee MS et al (2001) Doppler ultrasound imaging detects changes in tumor perfusion during antivascular therapy associated with vascular anatomic alterations Cancer Res 61:2974–2982
Miller JC et al (2005) Imaging angiogenesis: applications and potential for drug development. J Natl Cancer Inst 97:172–187
De Giorgi U et al (2005) Effect of angiosonography to monitor response during Imatinib treatment in patients with metastatic gastrointestinal stromal tumors. Clin Cancer Res 11:6171–6176
Krix M (2005) Quantification of enhancement in contrast ultrasound: a tool for monitoring of therapies in liver metastases. Eur Radiol 15(Suppl 5):104–108
giovagnoni A et al (2005) Evidence Based Medicine (EBM) and Evidence Based Radiology (EBR) in the follow-up of the patients after surgery for lung and colonrectal carcinoma. Radiol Med 109:345–357
Liberati A et al (1997) Assessing the effectiveness of follow-up care for colorectal cancer: a great conceptual and methodological challenge for clinical oncology. Ann Oncol 8:1059–1062
Puylaert JB (1986) Acute appendicitis: US evaluation using graded compression Radiology 158:355–360
Testa AC et al (2005) The use of contrasted transvaginal sonography in the diagnosis of gynecologic diseases. A preliminary study. J Ultrasound Med 24:1267–1278
Menzel J et al (2000) Gastrointestinal miniprobe sonography: the current status. Am J Gastroenterol 95:605–616
Harvey CJ et al (2002) Advances in ultrasound. Clin Radiol 57:157–177
Madrazo BL et al (2000) Doppler imaging. In: Shirkhoda A (eds) Variants and pitfalls in body imaging. Lippincott Williams & Wilkins, Philadelphia, 455–473
Lencioni R et al (2002) Tissue harmonic and contrast-specific imaging: back to gray scale in ultrasound. Eur Radiol 12:151–165
Szopinski KT et al (2003) Tissue harmonic imaging. Utility in breast sonography. J Ultrasound Med 22:479–487
Cha JH et al (2007) Characterization of benign and malignant solid breast masses: comparison of conventional US and tissue harmonic imaging. Radiology 242:63–69
Desser TS et al (2000) Native tissue harmonic imaging: basic principles and clinical applications Ultrasound Q 16:40–48
Rosenthal SJ et al (2001) Phase inversion tissue harmonic sonographic imaging: a clinical utility study. AJR Am J Roentgenol 176:1393–1398
Entrekin RR et al (2001) Real-time spatial compound imaging: application to breast, vascular, and musculoskeletal ultrasound. Semin Ultrasound CT MR 22:50–64
Oktar SÖ et al (2003) Comparison of conventional sonography, real-time compound sonography, tissue harmonic sonography, and tissue harmonic compound sonography of abdominal and pelvic lesions. AJR Am J Roentgenol 181:1341–1347
Mehta TS (2003) Current uses of ultrasound in the evaluation of the breast. Radiol Clin North Am 41:841–856
Kim SE et al (2003) Extended field-of-view sonography. Advantages in abdominal applications. J Ultrasound Med 22:385–394
Henrich W et al (2002) Transvaginal and transabdominal extended field-of-view (EFOV) and power Doppler EFOV sonography in gynecology. Advantages and applications J Ultrasound Med 21:1137–1144
Ying M et al (2006) Reliability of 3-D ultrasound measurements of cervical lymph node volume. Ultrasound Med Biol 32:995–1001
Bega G et al (2003) Three-dimensional ultrasonography in gynecology. Technical aspects and clinical applications J Ultrasound Med 22:1249–1269
Lyshchik A et al (2004) Three-dimensional ultrasonography for volume measurement of thyroid nodules in children. J Ultrasound Med 23:247–254
Alam F et al (2008) Accuracy of sonographic elastography in the differential diagnosis of enlarged cervical lymph nodes: comparison with conventional B-mode sonography AJR Am J Roentgenol 191:604–610
Giuseppetti GM et al (2005) Elastosonography in the diagnosis of the nodular breast lesions: preliminary report. Radiol Med 110:69–76
Zhi H et al (2007) Comparison of ultrasound elastography, mammography, and sonography in the diagnosis of solid breast lesions. J Ultrasound Med 26:807–815
Wachsberg RH (2003) B-flow, a non-Doppler technology for flow mapping: early experience in the abdomen. Ultrasound Q 19:114–122
Youk JK et al (2005) Focal fibrosis of the breast diagnosed by a sonographically guided core biopsy of nonpalpable lesions. Imaging findings and clinical relevance. J Ultrasound Med 24:1377–1384
Konno K et al (2001) Liver tumors in fatty liver: difficulty in ultrasonographic interpretation. Abdom Imaging 26:487–491
Riccabona M et al (1995) Distance and volume measurement using three-dimensional ultrasonography. J Ultrasound Med 14:881–886
Nishino M et al (2003) Primary retroperitoneal neoplasms: CT and MR imaging findings with anatomic and pathologic diagnostic clues. Radiographics 23:45–57
Moody AR et al (1993) Atypical hepatic hemangioma: a suggestive sonographic morphology. Radiology 188:413–417
Blachar A et al (2002) Hepatic capsular retraction: spectrum of benign and malignant etiologies. Abdom Imaging 27:690–699
Middleton WD (1998) Color Doppler. Image interpretation and optimization. Ultrasound Q 14:194–208
Taylor KJ (1995) Fulse Doppler and color flow of tumors. In: Taylor KJW et al (eds) Clinical applications of Doppler ultrasound, Raven Press, New York, 355–366
Grenier N et al (2001) Interpretation of Doppler signals. Eur Radiol 11:1295–1307
Hata K et al (2002) Prognostic significance of ultrasound derived peak systolic velocity in epithelial ovarian cancer. Ultrasound Obstet Gynecol 20:186–191
Kaushik S et al (2003) Spectral Doppler sonography of musculoskeletal soft tissue masses. J Ultrasound Med 22:1333–1336
del Cura JL et al (2005) The use of unenhanced Doppler sonography in the evaluation of solid breast lesions. AJR Am J Roentgenol 184:1788–1794
Özdemir A et al (2001) Differential diagnosis of solid breast lesions J Ultrasound Med 20:1091–1101
Bodner G et al (2002) Differentiation of malignant and benign musculoskeletal tumors: combined color and power Doppler US and spectral wave analysis. Radiology 223:410–416
Schick S et al (1998) Differentiation of benign and malignant tumors of the parotid gland: value of pulsed Doppler and color Doppler sonography. Eur Radiol 8:1462–1467
Hata K et al (1995) Intratumoral peak systolic velocity as a new possible predictor for detection of adnexal malignancy. Am J Obstet Gynecol 172:1496–1500
Brniç Z et al (2003) Usefulness of Doppler waveform analysis in differential diagnosis of cervical lymphadenopathy. Eur Radiol 13:175–180
Peters-Engl C et al (1999) Tumor flow in malignant breast tumors measured by Doppler ultrasound: an independent predictor of survival Breast Cancer Res Treat 54:65–71
Kubota K et al (2000) Evaluation of the intratumoral vasculature of hepatocellular carcinoma by power Doppler sonography: advantages and disadvantages versus conventional color Doppler sonography. Abdom Imaging 25:172–178
Schroeder RJ et al (2003) Role of power Doppler techniques and ultrasound contrast enhancement in the differential diagnosis of focal breast lesions. Eur Radiol 13:68–79
Quaia E (2005) Contrast media in ultrasonography. Basic principles and clinical applications Springer, Berlin
Wilson WD et al (2006) Sonographic quantification of ovarian tumor vascularity. J Ultrasound Med 25:1577–1581
Epstein E et al (2002) An algorithm including results of gray-scale and power Doppler ultrasound examination to predict endometrial malignancy in women with postmenopausal bleeding. Ultrasound Obstet Gynecol 20:370–376
De Marchi A et al (2002) A preliminary experience in the study of soft tissue superficial masses: color Doppler US and wash-in and wash-out curves with contrast media compared to histological results. Radiol Med 104:451–458
Numata K et al (1997) Use of hepatic tumor index on color Doppler sonography for differentiating large hepatic tumors. AJR Am J Roentgenol 168:991–995
Jeffrey RB et al (1995) Sonography of the abdomen. Raven Press, New York
Tanaka S et al (1990) Color-Doppler imaging of liver tumors. AJR Am J Roentgenol 154:509–514
Bartolozzi C et al (2001) contrast-specific ultrasound imaging of focal liver lesions. Prologue to a promising future. Eur Radiol 11(Suppl 3):13–14
Harvey CJ et al (2001) Developments in ultrasound contrast media. Eur Radiol 11:675–689
Liu J-B et al (2008) Contrast-enhanced ultrasound imaging. In: McGahan JP et al (eds) Diagnostic ultrasound, II edition. Informa Healthcare, New York, 39–62
Correas J-M et al (2001) Ultrasound contrast agents: properties, principles of action, tolerance, and artifacts. Eur Radiol 11:1316–1328
Piscaglia F et al (2006) The safety of Sono Vue® in abdominal applications: retrospective analysis of 23188 investigations. Ultrasound Med Biol 32:1369–1375
Forsberg F et al (1999) Tissue-specific US contrast agent for evaluation of hepatic and splenic parenchyma. Radiology 210:125–132
Numata K et al (2008) Ablation therapy guided by contrast-enhanced sonography with sonazoid for hepatocellular carcinoma lesions not detected by conventional sonography. J Ultrasound Med 27:395–406
Catalano O et al (2007b) Terminology for contrast-enhanced sonography: a practical glossary. J. Ultrasound Med 26:717–730
Bauer A et al (2002) Ultrasound imaging with Sono Vue: low mechanical index real-time imaging. Acad Radiol 9(Suppl 1): 282–284
Forsberg F et al (1994) Artifacts in ultrasonic contrast agent studies. J Ultrasound Med 13:357–365
Chami L et al (2007) Benefits of contrast-enhaced sonography for the detection of liver lesions: comparison with histologic findings AJR Am J Roentgenol 190:683–690
Claudon M et al (2008) Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS)-update 2008. Ultraschall Med 29:28–44
Catalano O et al (2005a) Real-time harmonic contrast material-specific US of focal liver lesions. Radiographics 25:333–349
Isozaki T et al (2003) Differential diagnosis of hepatic tumors by using contrast enhancement patterns at US. Radiology 229:798–805
Minami Y et al (2004) Treatment of hepatocellular carcinoma with radiofrequency ablation: usefulness of contrast harmonic sonography for lesions poorly defined with B-mode sonography. AJR Am J Roentgenol 183:153–156
Solbiati L et al (1997) Hepatic metastases: percutaneous radiofrequency ablation with cooled-tip electrodes. Radiology 205:367–373
Quaia E et al (2007) Diagnostic value of hepatocellular nodule vascularity after microbubble injection for characterizing malignancy in patients with cirrhosis. AJR Am J Roentgenol 189:1474–1483
Burns PN et al (2007) Focal liver masses: enhancement patterns of contrast-enhanced images-concordance of US scans with CT scans and MR images. Radiology 242:162–174
Catalano O et al (2006a) Contrast-enhanced sonography of the spleen. Semin Ultrasound CT and MRI 27:426–433
Thorelius L (2003) Contrast-enhanced ultrasound: beyond the liver. Eur Radiol 13(Suppl 3): 91–108
Robbin ML et al (2003) Renal imaging with ultrasound contrast: current status. Radiol Clin North Am 41:963–978
Rights and permissions
Copyright information
© 2009 Springer-Verlag Italia
About this chapter
Cite this chapter
(2009). General Considerations. In: Fundamentals in Oncologic Ultrasound. Springer, Milano. https://doi.org/10.1007/978-88-470-1355-1_1
Download citation
DOI: https://doi.org/10.1007/978-88-470-1355-1_1
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-1354-4
Online ISBN: 978-88-470-1355-1
eBook Packages: MedicineMedicine (R0)